A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina

This study is ongoing, but not recruiting participants.

Sponsored by:	University of Toronto
Information provided by:	University of Toronto
ClinicalTrials.gov Identifier:	NCT00350922

Purpose

The purpose of this clinical trial was to determine the effectiveness of a supportive and educational self-management program for improving health-related quality of life (HRQOL), angina symptoms, and self-efficacy and resourcefulness to self-manage for chronic angina patients. 130 participants were enrolled in the trial for 3 months. The program, entitled the Chronic Angina Self-Management Program, (CASMP) was found effective for improving HRQOL, angina symptoms, and self-efficacy to manage symptoms, compared to usual care.

Condition	Intervention	Phase
Chronic Stable Angina	Behavioral: Psychoeducation	Phase I

MedlinePlus related topics: Angina

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Official Title:	A Psychoeducation Trial for People With Chronic Stable Angina

Further study details as provided by University of Toronto:

Primary Outcome Measures:

SF36
Seattle Angina Questionnaire

Secondary Outcome Measures:

Self-Efficacy Scale
Self-Control Schedule

Estimated Enrollment:	130
Study Start Date:	September 2003
Estimated Study Completion Date:	November 2005

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Medical diagnosis of coronary artery disease CCS Class I-III Angina for at least 6 months Speak, read, understand English -

Exclusion Criteria:

MI/Bypass last 6 months CCS Class IV angina A major cognitive disorder -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350922

Locations

Canada, Ontario
University of Toronto
Toronto, Ontario, Canada, M5T 1P8

Sponsors and Collaborators

University of Toronto

Investigators

Study Director:	Judy H Watt-Watson, PhD	University of Toronto
Principal Investigator:	Michael H McGillion, PhD	University of Toronto

More Information

Study ID Numbers:	452639
Study First Received:	July 8, 2006
Last Updated:	July 8, 2006
ClinicalTrials.gov Identifier:	NCT00350922
Health Authority:	Canada: Ethics Review Committee

Study placed in the following topic categories:

Signs and Symptoms
Heart Diseases
Myocardial Ischemia
Vascular Diseases

Angina Pectoris
Pain
Ischemia
Chest Pain

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009